Good morning.
Futures flat to slightly green after Juneteenth closure — S&P implied +0.2%, Nasdaq +0.4%. Semis leading again off Friday’s SOXX +6% and Intel’s +10.6% Apple partnership pop. No major earnings prints overnight, but MU is the elephant in the room this week. Asia mixed: Japan semi-related names surging (Taiyo Yuden +211% over two months, Murata +155%) while China tech soft on renewed EUV probe noise. Strait of Hormuz restrictions keep oil bid, but managed money is short — contrarian setup for a spike.
Three big themes framing today:
1. OPTICAL OVERBUILD IS A LIE. The bear narrative counts 90-100M 400G+ transceivers vs. 14-15M XPUs and calls it oversupply. Reality: backend attach runs 1:3.5, add frontend and IDC upgrades and real demand is closer to 100M units. This is an undersupply environment. Bullish for the entire networking stack — and for anyone long MU, since HBM attach scales with cluster size.
2. ENTERPRISE AI HITS A COST WALL. Deloitte says CFOs are pulling back on API spend. Compute costs are forcing a pivot to local open-source models. This is a direct headwind to CRM, ACN, and the entire application layer — unless they prove they can compress inference economics. SHOP and TWLO need to show they’re not just API toll booths.
3. MEMORY SHORTAGE GETS REAL. Apple’s Cook confirmed price hikes on memory-constrained products. Nothing canceled a budget phone due to RAM costs. HBM roadmap shift (Rubin Ultra from 16-Hi to 12-Hi) changes the packaging math but doesn’t break the 3-player oligopoly thesis. JPM sees Kioxia +43% upside. MU’s print this week is the catalyst.
We’ll hit up MU, CRM, and JBL first, then get to the semi supply chain and optical plays.
Verdict: Consensus long, but the setup is getting crowded ahead of earnings on June 24. Eight firms raised PTs in the last 48 hours, clustering between $1,200 (Rosenblatt, RBC) and $1,600 (Aletheia), with the modal target at $1,500 (DB, Stifel, TD Cowen). Stock at $1,043, up 758% in a year. The bull case is a straight line: AI-induced DRAM shortage that persists through 2028, with HBM as the swing factor. The bear case is harder to find — every sell-sider is on the same side of the boat.
PT range: $1,200 to $1,600. Consensus EPS for CY27 is now drifting toward $150-160 (DB at $160, TD Cowen at $150). Valuations range from 9x-10x CY27 EPS + net cash (Wedbush, Rosenblatt) to something more heroic at Aletheia. The common thread: this cycle is different — structural undersupply of wafer capacity, strategic customer agreements locking in multi-year pricing, and gross margins sustaining in the 80%+ range (DB's call). The old 18-month memory cycle playbook is being thrown out.
BULL: AI workloads are DRAM-hungry in ways the market still underestimates. Traditional DRAM ASPs (ex-HBM) are already above $2.50/GB for server, with consumer/mobile above $1.50/GB (Stifel). HBM pricing could be revised up 50%+ for 2027. New wafer supply is 12 months away, and demand hasn't slowed. Long-term agreements (Strategic Customer Agreements) should flatten the peak-to-trough shape — Wedbush calls it "a more sustained period of peak earnings." DB sees the imbalance running "well into 2028."
"The key battleground is for HBM, which our checks suggest could be revised up meaningfully, by more than 50% year-over-year, for 2027." — Stifel
BEAR: The stock is up 758% in a year. It sits on InvestingPro's "Most Overvalued" list. Peak-cycle multiples (9-10x forward EPS) are already being applied to peakish numbers. If HBM pricing decelerates or if hyperscalers slow procurement (they've been front-loading), the downward revision cycle could be vicious. Options imply an 11% move post-earnings — not exactly a low-uncertainty setup. The bullish consensus means everyone's already long; who's left to buy?
Most of this was already known: the soft pre-announcement, the ongoing DRAM upcycle, the Bechtel fab contract. What's new is the speed and magnitude of analyst revisions. Stifel went from $550 to $1,500 — that's a 173% PT hike in one move. Wedbush from $500 to $1,300. Rosenblatt's call is more conservative but still a 20%+ upside from here. The collective message: May-quarter revenue will print ABOVE the high end of guidance (DB modeling $35.1B). The question is how much of this is already in the stock.
Peers: HBM suppliers (SK Hynix, Samsung not listed), but also semi equipment (AMAT, LRCX, KLAC) if you believe the capex cycle is extending. AI memory demand is a direct tailwind for NAND as well (WDC, STX). Thematic narrative: The megacap AI spend cycle is now explicitly a memory cycle, not just compute. That shifts the conversation from NVDA's GPU cadence to HBM supply constraints. If MU guides up on June 24, expect a sympathy bump across memory and semi equipment. If they guide inline and call peak cycle — look out below.
JBL IS ON A TEAR — three analyst upgrades in one session, all pointing to the AI infrastructure super-cycle embedding into the model. Stifel and BofA both raised to $460 and $470 (Buy), UBS went to $430 (Neutral). The range tells you the bull/bear tension: massive top-line momentum vs. a 51x P/E that demands flawless execution.
FQ3 print crushed: $8.8B revenue (vs $8.55B consensus), 5.8% op margin (beat by 10bps), $3.16 EPS. Guidance for FY26 raised to ~$35B rev, $12.70 EPS, $1.4B+ FCF. The headline number? AI REVENUE NOW GUIDED TO $13.6B FOR FY26 — THAT'S +50% YoY. Management dropped an early FY27 view of "similar percentage growth" → implies ~$20B in AI rev next year.
Three bullet points to know:
Bull case: JBL is becoming the premier AI manufacturing partner — three hyperscalers, Nvidia, Adani — and margins are finally inflecting. The 50% AI growth rate for two more years is conservatism, not guidance. $470 target still only ~20x FY27 EPS. The FCF generation ($1.4B+) funds buybacks. PEG ratio of 0.62 — cheap for this growth.
Bear case: 51x trailing P/E prices in perfection. The third hyperscaler isn't named — could be a Tier-2 player. The Adani deal is years away. UBS notes that at ~13% normalized consolidated growth, the current valuation leaves zero room for a capex cycle slowdown. If AI demand hiccups, this stock gets cut in half.
BofA's thesis is tightest:
"Expects operating margin to increase 20 to 30 basis points year-over-year for the next several years."
That's the key. AI scale brings fixed cost leverage. If JBL can deliver 6%+ op margins consistently, the stock works even at 20x forward earnings. The $470 PT is 28% upside from here — not crazy for a stock that just printed 83% in 12 months.
Bottom line: JBL is in the sweet spot of the AI buildout — less crowded than the chip names, more tangible than the software plays. The neutral case ($430) isn't bearish, it's just "pay me later." The bulls are betting the margin story has years left to run.
THE GLASSES ARE REAL, BUT THE STOCK ISN’T WEARING THEM YET. SPECS launch got the headlines, but the Street isn’t buying the re-rate. Six firms chimed in — most stuck at Hold/Neutral, PTs clustered $5.75-$8.00. B.Riley stands alone at Buy/$10, but that’s the outlier, not the signal.
Piper Sandler, Truist, Stifel, Benchmark, Citizens — all reiterate Neutral/Hold/Market Perform. PTs $5.75 to $8.00. Core thesis: the glasses are a technical demo, not a P&L driver. Truist explicitly says NO NEAR-TERM IMPACT ON SNAP’S P&L. Benchmark flags missing specs (resolution, PPD, brightness, refresh rate) on a $2,195 device targeting 100,000 UNITS initial run — not exactly a mass-market wave.
BULL: SPECS is optically see-through AR at a 51-degree FOV — genuinely differentiated from Meta’s $799 Ray-Ban Display (20-degree FOV, monocular). If they ship well and developer traction builds, it’s an optionality franchise. B.Riley’s $10 target leans into that.
BEAR: $2,195 price point + developer-kit positioning = zero consumer demand this cycle. Meta owns the low-end volume, Apple’s Vision Pro is $3,500 with a full OS. Snap’s glasses are a boutique experiment. Core ad business is still bleeding (stock -36% YTD). Execution on the turnaround is the only thing that saves the stock, not hardware heroics.
From Benchmark’s Zgutowicz on the technical gap: "The device lacks disclosed specifications for resolution, pixels per degree, brightness, and refresh rate." On a premium AR device you’re asking developers to pay $2,200 for, leaving those specs off the datasheet tells you exactly where the product stands — more proof-of-concept than production-ready. Stretch goal of 100k units (per Spiegel) is caution, not conviction.
Monness upgrades CRM to Buy at $200 — calling the valuation too cheap to ignore after a 41% YTD collapse. Stock is literally 1% off its 52-week low at $155, down 58% from the late-2024 ATH. That’s the second-worst performer in their coverage universe.
The rationale isn’t about a catalyst — it’s about price. P/E of 18.1, PEG of 0.47, FCF yield of 12%, gross margins at 77.6%. Monness likes the margin profile, cash flow, and the buyback machine. They also mention the “agentic enterprise” transition as a real thing, even if the market is pricing CRM like it’s dead money.
On the same day, CRM announced the $3.6B acquisition of Fin (Intercom) — an AI customer service platform with $400M+ ARR and a 76% autonomous resolution rate. Street reaction is broadly positive: Jefferies, Canaccord, Stifel, and Wolfe all maintain Buy ratings with PTs ranging $220–250. UBS sits alone at Neutral/$185, not convinced the deal moves the needle near-term.
Call it a value trap or a deep value setup — but the r/r is finally interesting for a name that’s been left for dead. The bull case: multiple compression is overdone, buybacks + FCF provide a floor, and the Fin deal accelerates AI adoption in the installed base. The bear case: AI is structurally deflating software valuations, and $155 could break if macro worsens. Either way, Monness stepping up after a 41% drawdown is a signal worth listening to.
The CPU narrative is getting repriced, fast. Bernstein (and Mizuho) both now pin a $500 target on ARM — 23% upside from here but that's almost immaterial given the 246% run over six months. The thesis: ARM is no longer just an IP licensor. It's a CPU maker for agentic AI workloads, and the market is finally starting to model that revenue step-change.
Bernstein jacked its 2030 revenue estimate to $22B (from $15B) after re-scoping the CPU TAM to $223B (from $137B). EPS for FY31 goes to $11.79. That's a 42x multiple on that number — only 2 turns of multiple expansion from the prior 40x, so the PT move is mostly fundamental, not just multiple creep. The stock currently sports a 476x trailing P/E, so this is a long-duration bet on the hockey stick.
Old IP licensing model? Dead. They're building a business that competes with x86 and custom silicon for AI inference at the edge and in the cloud. The power efficiency angle is the hook for agentic AI (always-on, low-latency workloads).
"Arm’s architecture is suitable for agentic AI given its power efficiency." — Bernstein
The risk: execution on the shift from royalty-per-chip to selling full CPU solutions, plus the geopolitical headache of AI-capable CPU export controls (CEO Haas flagged this). But for now, the rate of change in the narrative is violently positive.
Subscription rollout is a long-duration option, not a near-term needle-mover. Evercore reiterates Outperform / $930 as META launches paid tiers across its Family of Apps (Plus, Meta One AI, business/creator plans). The near-term revenue impact is negligible — phased rollout + low initial conversion. But the math is blindingly simple: 3.6B DAUs, even 1% penetration at modest ARPU = huge high-margin stream. META already prints 82% gross margins on $215B revenue growing 26% y/y. Subscriptions add incremental upside to an already beastly operating model.
"Even modest penetration against Meta’s ecosystem of more than 3.6 billion daily users could create a meaningful high-margin revenue stream over time."
Not a catalyst for this month. But as a 3-5 year margin expansion story, the optionality is real. Threads hitting 500M MAUs is a nice reminder the platform flywheel isn't slowing.
Two analyst initiations this morning — both bullish, both focused on the MRC merger reshaping this name. Freedom Broker starts with Buy, $16 PT (17% upside). DA Davidson also goes Buy, $17 PT (10x CY27 EBITDA). The combined thesis: merger is a game-changer for scale and diversification.
The merger thesis: revenue up 41% LTM to $3.4B. Shifting mix away from pure upstream cyclicality into gas utility, downstream, and industrial — less volatile, better visibility. Procurement synergies and cross-sell are real levers. The Q1 print had an ugly EPS miss ($0.01 vs $0.11 consensus), but revenue beat — and these guys are looking through that.
"The MRC integration, rising midstream and natural gas infrastructure investment, and a more balanced revenue base support a constructive medium-term outlook."
Caveat: EPS miss was nasty (90% negative surprise). Not sure we can fully hand-wave that, especially in a tape that’s punishing earnings misses. But the revenue beat and the strategic pivot give the bulls cover. Risk/reward looks decent if you believe the merger math holds — $16-17 PT cluster implies ~20% upside from here. Worth a look for PMs rotating into industrial distribution.
Verdict: APLD is the hottest pick-and-shovel in AI infrastructure right now. 810 MW leased to a new hyperscaler in just 60 days — that’s not just execution, that’s a signal that the supply-constrained market is real and APLD is one of the few with grid-connected dirt. Northland jacks PT to $82 (from $56), and others follow: Craig-Hallum to $79, Lake Street to $90, Compass Point stuck at $70 but still a Buy. Revenue growth 193% FY forecasts, $36B in contracted base-term lease revenue. Net of the DF2 lease, another ~1 GW of critical IT load being actively marketed. The only caveat: the $1.59B senior secured note offering (7% coupon, due 2031) adds leverage, but given the demand backdrop, that’s fuel for the next leg.
“The company’s management, site sourcing, and development team is executing at an extremely high level.” — Northland’s Mike Grondahl
Upgrade from DA Davidson breaks the bearish spell, but this stock is still fighting for credibility. They moved to Buy from Neutral, PT stuck at $110 (stock at $83, near 52-week low). Thesis: the AI disruption narrative is overblown relative to what’s actually happening in contact centers. They spoke to customers at NICE’s annual user event and came away convinced.
“Investor perception of AI disruption appears more negative than the actual developments occurring within contact centers.”
Valuation is the hook. DA Davidson values NICE at 9x 2027 EPS; the stock currently trades below 7x on both a relative and historical basis. That’s cheap for a company with 66% YoY AI ARR growth and cloud backlog up 18% (Q1 beat: $787M revenue vs $761M consensus, $2.64 EPS vs $2.52). BUT – management guided cloud revenue growth DOWN to 13-15% from 14-15%. That’s the rate-of-change problem.
Analyst sentiment is split but not toxic. BofA cut PT to $165 ($200) but kept Buy. Citizens to $170 ($200), Market Outperform. Meanwhile DA Davidson upgrades. The consensus is that the baby is being thrown out with the bathwater – Actimize sale optionality, AI feature monetization, and a discounted multiple all point to asymmetric upside. The market is pricing in a worst-case AI disruption that hasn’t materialized.
Risks remain real. The cloud growth deceleration is a legit headwind. And the stock has been bleeding all year – $83 is a stone’s throw from its 52-week low. PMs should watch for the next quarterly print to confirm if that AI ARR momentum can offset the guidance trim. For now, the r/r is compelling if you believe the narrative gap closes.
BofA keeps Buy, $310 PT. The Prime Day calendar shift is the story – pulled to June from July, dragging ~$12.4B INCREMENTAL Q2 GMV into the quarter. That sets up a Q2 beat but a material comp headwind in Q3. The 5% total GMV growth looks pedestrian vs last year's 55% (which was inflated by the 96-hour window expansion), but May card data shows retail momentum still strong. Revenue tracking at or above $199B guide.
"BofA believes Amazon is on track to come in at or above the high end of its second-quarter revenue guidance of $199 billion."
BTIG and BWS Financial both lit up ATEN this week — BTIG lifting its PT to $37 (from $30, Buy maintained) and BWS going even bigger to $45. The stock sits at $33.26, a stone’s throw from the 52-week high, and it’s already up 87% YTD. The catalyst is pure AI infrastructure demand — ATEN’s next-gen security and networking gear is benefiting from a structural wave, and the TrojAI acquisition adds an AI security layer that makes the story stickier.
The numbers back it up: LTM revenue growth of 12%, gross margins at 79%, and management just guided to 12%+ annual revenue growth over the next three years. The largest customer concentration (31% of TTM rev) is a bogey, but BTIG’s conversation with VP David Schroeder gave them confidence the dynamics are healthy and the base is improving. BWS is even more aggressive, seeing accelerated rev and FCF growth off the AI demand curve.
“We came away from the discussion more constructive on the stock. The TrojAI acquisition broadens the security roadmap and improves the AI firewall story.”
Not a ton of coverage here — just two firms — but the direction is unanimous. ATEN is small, cheap relative to growth (79% gross margins, 12% organic rev), and has a real AI angle in enterprise and service provider land. The risk is concentration and execution, but the rate of change is clearly positive.
Rosenblatt reiterates Buy / $230 PT after field check with digital agency exec Happy Cog. Verdict: bull case intact, new AI products gaining traction in real-world deployments. The channel check matters here because this isn't some sell-side analyst modeling pennies — it's a conversation with someone actually building on the platform.
"Balanced and credible, neither overselling nor underselling" — that's the gold standard for a field check descriptor.
The call covered the new product suite (Conversation Orchestrator, Memory, Relay, Voice AI) and the exec has production experience with Twilio's core comms and auth platforms. Not a theoretical bull case. Real deployment.
Wider analyst community is aligned. Multiple firms (Tigress to $255, Oppenheimer to $235, Needham to $250, TD Cowen to $210) have raised targets post-Signal conference in a $210-255 cluster. Collective thesis: the restructuring (40% headcount reduction from peak) + AI product cycle = profitable growth inflection.
Stock returned 61% over the past year but the real bogey is whether the AI-driven revenue acceleration shows up in the numbers. So far, data points support the thesis. Rate of change is positive.
JPMorgan is throwing cold water on the TPU v9 delay narrative. They reiterated Overweight/$580, saying the 2nm chip ramp is on track for 2028 – no cancels, no slips. The sell-side rumor mill was wrong. This is a bet on Google’s internal COT team lagging Broadcom by 18 months, plus a locked-in roadmap through v11. The stock’s $1.89T market cap means every win needs to be huge; this is a "business as usual" affirmation, not a catalyst.
"Broadcom remains on track to ramp its next-generation TPU v9 2nm chip in 2028 with no delays or cancellations, contrary to recent reports from sell-side analysts, Asia supply chain sources, and news outlets."
Keep an eye on the v8i qualification (done mid-2025, ramping this quarter) as the near-term proof point. The real story is the 18-month lead on Google’s in-house team – that’s the moat.
Goldman Sachs opens coverage with a Buy and $499 PT — a 29% total return call. Three pillars: (1) the 17-year AWS PPA transforms TLN from pure merchant into a hybrid contracted/merchant generator, slashing cash flow volatility. (2) 99% of capacity in PJM gives it the most direct lever on tightening supply/demand and data center load growth among the IPP bunch. (3) Smaller EBITDA base means any incremental PPA moves the needle more vs. peers.
"The stock trades at 9.1x forward year-two EV/EBITDA, near recent trough levels, suggesting the market has not fully priced in the structural improvement in the business model."
That multiple — basically trough, post-deal — implies the market is still pricing TLN like a legacy merchant name. GS sees the floor from contracted earnings and the option value from more hyperscaler deals as unappreciated. If you buy the PJM structural tightening thesis, TLN is the cleanest way to play it.
BARCLAYS INITIATES AT EQUALWEIGHT, $18 TARGET – stock at $16.54, basically hugging its 52-week low ($16.53). Thesis is cautious on top-line: Octave’s mid-term targets (6-8% rev growth from 3% in FY25) depend on pushing existing customer growth much higher while new customer growth is only ~3.5%. Barclays sees 5.5% existing customer growth driving 9% ARR CAGR through FY30, implying ~6% total revenue – 5% below consensus. High margins (76% gross) are nice, but up-sell/cross-sell is uncertain and price increases get offset by churn.
"Barclays expects some acceleration in existing customer growth but remains cautious on up-selling and cross-selling opportunities."
Other recent coverage (Evercore In Line/$20, RBC Sector Perform/$21, GS Neutral/$17) all cluster in the $17-21 range, so the bar isn't high – but the stock is already there. No positive catalyst visible near-term.
TD Cowen throwing its weight behind FROG this morning — adds to Best SmidCap Ideas list and hikes PT to $100 from $80. Stock already ripping: UP ~96% OVER THE PAST YEAR, 30% YTD. At $79.54, the new PT implies ~25% upside. The call is all about AI-driven software complexity.
Thesis is straightforward: coding agents (Claude, Copilot, etc.) are exploding the number of software packages and artifacts that need to be managed. FROG sits at the center of that — they're the plumbing for software supply chain governance. TD Cowen sees this as durable, not ephemeral. Points to 77% gross margins and 25% revenue growth as proof of business quality.
"Coding agents are causing a significant increase in the amount of software packages."
AI tailwinds are just getting started. More code generation = more packages = more need for FROG's platform. The Claude Code plugin launch with Anthropic is a tangible proof point — real integration, not vaporware. TD Cowen also calls out Curation (security product) as an incremental growth driver. They think premium valuation is justified given growth durability ABOVE 20%. For a smid-cap in this rate environment, that's a bet on structural demand.
Stifel recently bumped PT to $85 citing $350K average customer spend (that's healthy expansion). Cantor reiterated Overweight at $80. The Russell 3000 inclusion June 26 adds a passive flow bid. Three separate firms all saying the same thing: this works.
Valuation is the obvious bogey. 25% revenue growth is strong but not hyperscale — you're paying for a premium multiple on a smid-cap DevOps tool. Competition from GitLab, GitHub, and the cloud providers is real. Curation is a nice product but not a moat. If AI coding agents become commoditized or the package explosion thesis doesn't compound as expected, multiple compression hits hard. Not sure we can read too much into the Russell inclusion — it's a one-time event, not a recurring catalyst.
Verdict: Stifel throws in the towel. Downgrade to Hold with PT slashed to $275 from $375. The thesis is clear: Intuit’s pricing power is cracking. After years of aggressive price hikes at the low end, they’re pivoting to value-based pricing to stop share loss. That means lower near-term growth guides for both TurboTax (4-6% vs prior 6-10%) and QuickBooks Global (10-15% vs 15-20%). The stock is already at a 52-week low ($268) after a 65% Y/Y drawdown. At 10x CY27 non-GAAP EPS it looks cheap, but the rate of change in the growth story is what matters—and it’s heading down.
"Stifel projects TurboTax near-term guidance will be reduced to 4-6% from the current management target of 6-10%."
Broader consensus is fracturing. Yes, Q3 FY26 beat (revenue $8.56B, +10.4% y/y, 54.7% margins), but the DIY tax headwind is real. Freedom Broker already downgraded to Hold on IRS competition (PT $430). Truist, KeyBanc, Mizuho all cut PTs to $400-500 range, though some maintain Buy/Overweight. BofA resumed Buy at $400. The bull case rests on TurboTax Live growth and mid-teens EPS growth promises; the bear case is this is a structural shift, not a one-time reset. Right now the market is pricing the bear.
Goldman starts CEG at Neutral. $305 PT. Verdict: great assets, wrong price. They love the nuclear fleet (22GW, largest in US), the balance sheet (net debt/EBITDA back to 1.5-2x post-Calpine), and the hyperscaler demand angle. But they don't love the valuation.
17% implied upside vs 31% median for IPP coverage. Stock trades 3 TURNS ABOVE VISTRA on FY2 EV/EBITDA and carries the LOWEST FCF YIELD in GS' coverage. At 12.3x FY2 EV/EBITDA, it's basically at its own 5-year average (12.4x). No multiple expansion catalyst from here, in their view.
They'd rather play the power demand trade through Talen, Vistra, or NRG — better entry points, more unpriced optionality.
"We prefer to express our positive view on the power demand theme through Talen Energy, Vistra and NRG Energy, citing more attractive valuation entry points and greater optionality not yet priced in."
The take for PMs: CEG is the quality name in nuclear, but the r/r is compressed. If you're long the theme, you're paying for perfection. Better to wait for a pullback or rotate into names where optionality is still being discounted.
Cummins is printing AI tailwinds. The 2 GW natural gas generator order from Circe Energy for West Texas data centers is a massive multi-year commitment (2026-2030). UBS is staying long with an $850 PT, and the stock is up 126% in the past year to ~$727, now near its 52-week high. At 36.6x earnings and a $100B market cap, the multiple is rich—but this deal validates the narrative that natural gas-fired backup gen is becoming a core AI infrastructure layer, not just a cyclical industrial product.
"The order represents a significant commitment to natural gas-powered generation for AI data center infrastructure development over the next four years."
Not sure we can read too much into a single order—2 GW over five years is meaningful but not life-changing for a $16B revenue company. The rate of change in AI power demand is the real story. CMI’s Power business is now the growth engine, and UBS sees EPS hitting $41.25 by 2028 (from ~$30 in 2026). Truck business is the swing factor, but the bull case hinges on whether datacenter gen can sustain the upward revision cycle. Right now, it's working.
MBLY'S ROBOTAXI PIVOT IS A DOUBLE-EDGED SWORD. UBS NEUTRAL, BERENBERG DOWNGRADES TO HOLD — DESPITE THE Q1 BEAT. Stock at $9.06, PTs clustered at $10-10.80. The company announced plans to launch its own autonomous ride-hailing service in a U.S. city by 2027, starting with ~100 safety-driver-equipped vehicles. Initial capex is a trivial ~$5M (cash on hand: $1.2B). Scaling to 17,000 vehicles would cost ~$850M — fundable by cash flow from operations, they claim. But the real tension is structural: Mobileye is now competing with its own customers.
UBS noted there is more tension in that relationship now.
Berenberg cut to Hold (from Buy) despite raising PT to $10.80 from $9.30 — the stock has rallied ~47% since their March initiation. The Q1 beat was real (EPS $0.12 vs $0.09, rev $558M vs $519.5M), driven by Chinese OEMs and Western ADAS uptake. But the robotaxi direct-to-consumer model shifts the narrative from a pure-play tech supplier to a capital-light-or-is-it operator. UBS isn't modeling meaningful financial impact from the initial phase. The bull case: Mobileye monetizes its tech stack vertically and captures ride-hailing margin. The bear case: OEMs balk, the scaling timeline slips, and the $850M capex bill comes due before the unit economics prove out. At $9.06, the market is pricing in the optionality, not the execution risk. I'd wait for a cheaper entry or a clearer OEM partnership signal.
SHOP at $108, -35% over 6 months, $140B market cap. The Spring 2026 Editions drop is the headline catalyst — AI-driven product velocity (Catalog, UCP) reinforces the "shopping everywhere" thesis. Revenue growth still running 32%, Q1 GMV +30% y/y (ex-FX), EBIT beat by 14%. Yet the stock is getting crushed. That's the tension.
Consensus on product execution is strong, but the analyst split is real. Citizens sticks with Market Outperform / $150, calling Shopify the "de facto starting point for new merchants" and AI a net tailwind. Piper Sandler agrees at $150 Overweight. UBS is neutral at $130 (flagging Retail POS as the long-term growth driver). Cantor is outright cautious at $115 Neutral, citing margin concerns. The $100M Thrive Capital investment adds a bull flag on AI-commerce optionality.
"Commerce is evolving with an uncertain end state, but Shopify is building its product roadmap to service consumers regardless of how they want to interact." — Citizens
Bottom line: fundamental trajectory is intact, but the stock needs to prove it can hold these growth rates without margin compression. The 6-month drawdown says PMs are leaning bear on r/r. I'd watch GMV acceleration and free cash flow in the next print — the product update gives the narrative a hook, but the tape is telling you to stay patient.
Verdict: The AI workload migration trade is alive, but the risk/reward is getting tighter. Northland doubles down on the shift-to-on-prem narrative, pointing to AMBA's 2nm ASIC deals as proof of concept. The stock is $67, target $101 — but that consensus range ($80-120) tells you the street is already pricing in some of this.
The core thesis here isn't about automotive or IoT — it's about enterprise AI inference moving on-prem. Northland argues one-size-fits-all cloud compute doesn't cut it for performance/power/cost requirements across different enterprise environments. AMBA's two 2nm ASIC development agreements signed in the last year (including the Hanwha $800M/10yr deal) are the tangible evidence. Revenue +28% LTM, 8 analyst EPS revisions up — the fundamental arrow points north.
"Enterprise environments require a wide range of performance specifications across performance, power, and cost considerations. One size does not fit all."
The bull case is clean: AMBA sits at the intersection of bespoke silicon demand and a structural CAPEX shift. But Summit just downgraded to Hold on H2 2026 supply chain risk — that's the bear flag. The Q1 beat ($0.11 vs $0.10 est) was modest, and the PT cluster ($96-120 from BofA/Stifel/Rosenblatt) suggests upside is real but capped near $100-120 without a catalyst step-change. For a 9-figure book, this is a tactical long against the on-prem theme, not a core position — watch for the 2nm tape-outs to derisk the supply chain concern.
Oppenheimer stays on the sidelines but is clearly signaling they think the Physical AI capex story is real. They reiterated Perform (no rating upgrade, no downgrade — just a data-point dump) but jacked 2026 capex to $29.4B, a FULL 25% ABOVE THE $23.5B STREET CONSENSUS. That’s a massive delta. They’re essentially saying “if you believe the AI infrastructure buildout, Tesla is the most levered name.” Also worth noting: they added $2.5B in marketable securities gains from the SpaceX IPO — a small tailwind but not the driver.
The real meat is the narrative shift. Oppenheimer thinks investors will start looking at capex as a leading indicator of Physical AI success, not a cost. That’s a clever framing — turns a spending blowout into a signal. They expect an upward trading bias into Q2 earnings (probably because capex guidance gets another leg higher).
“The Tesla narrative has shifted to Physical AI leadership, with investors increasingly focused on the company’s ability to bring power capacity through solar and storage to market and accelerate learning cycles for the platform.”
The Perform rating keeps them off the “buy the stock” list, but they’re building the bull case for later. If you’re long TSLA, you want the capex thesis to gain believers. If you’re short, you’re betting the capex gets wasted (or the learning cycles don’t materialize). Deep disagreement in PTs ($62–$401) tells you nobody has conviction yet. Just positioning noise for now.
William Blair throws in the towel. Downgraded to Market Perform (from Outperform) and yanked off the firm's Analyst Conviction List. The call isn't about Q3 print alone — it's the forward demand trajectory and a "softer implied exit rate into fiscal 2027" that seals it. Stock is off 41% from its 52-week high, now ~$126, and the street is starting to price in structural deceleration, not just macro noise.
"Accenture’s fiscal third-quarter results, guidance, and commentary point to weakening forward demand and a softer implied exit rate into fiscal 2027. Therefore, we are downgrading Accenture to Market Perform and removing it from our Analyst Conviction List."
Other houses are split — UBS still Buy at $320 (pre-print), Berenberg cut to $220 from $273 citing sector-wide de-rating. Meanwhile, management keeps M&A active (Dragos for $4.2B, runZero, NetRise, Alfahealth, IxG) — classic ACN: buy growth when organic slows. But the issue isn't portfolio; it's the top-line rhythm. If FY2027 exit rate is softening, the multiple has further to compress.
"With valuation having come in significantly this year and AI seemingly a tailwind rather than risk, we remain bullish."
Q1 already validated the story: EPS of $1.61 crushed the $1.13 consensus, revenue $10.5B vs $9.4B expected. Raymond James followed with a PT bump to $181 (Outperform). The new investor presentation laid out attractive long-term targets — think organic growth + M&A + capital returns. Data center exposure is the immediate catalyst, but the broader pitch is a diversified services platform generating ample cash in a recovering CRE cycle. Bull case works.
Citizens reiterates Market Perform, and the logic is clean: consensus already bakes in a 2027 price hike. Stock at $76.96 (near 52-week low of $75.01), down 37% in a year. P/E of 24.9, PEG of 0.53 – optically cheap, but that’s the trap if revenue upside is already discounted.
Analyst Matthew Condon runs the math on consensus 2027 revenue components and concludes there’s no room for upside surprise from pricing. He also recently trimmed 2027 net sub adds on engagement headwinds. Thinks a 2027 hike is highly likely – just already reflected.
“After analyzing components of consensus 2027 revenue estimates, the firm believes they already imply a 2027 price increase, leaving little room for upside to revenue projections.”
Bull case (Bernstein Outperform, mentioned in article) points to business model strength. Bear case: no near-term catalysts, engagement momentum fading, and the M&A chatter (Roku loss, potential Lionsgate bid) feels like a distraction, not a solution. The 15% Canadian content regulation adds a modest cost headwind, but not the primary issue.
Verdict: Priced for a pricing hike. That’s the irony – correct macro view, but consensus already there. No edge yet. Pass.
NEUTRAL VIBE FROM UBS DESPITE JUNIPER INTEGRATION SHOWING REAL TRACTION. Stock up 178% in a year — that’s a lot of good news priced in at $49.75. UBS keeps $65 PT and Neutral, but they’re clearly more comfortable with the story post-Discover 2026. Marvis AI engine is being stitched into everything from data center switches to campus CX gear. Self-driving networks that auto-diagnose and fix? That’s the narrative hook.
“Self-driving networks that can predict, diagnose, and fix network challenges automatically eliminating manual remediation should be the future of networking design in an AI-centric world.”
The good: Backlog elevated, refreshed portfolio, 8-12% networking revenue growth next year feels achievable. 17 analysts revised estimates up.
The caveat: Revenue still gated by supply constraints into FY2027. Component availability is the bottleneck, not demand. That’s a known known, but it caps near-term upside until visibility improves. For a stock up 178%, the market is already pricing a clean ramp — any hiccup in supply chain and this thing gets hit.
Bottom line: Thesis intact, execution improving, but r/r less compelling at these levels. Neutral makes sense.
Truist staying the course at Buy / $18, but the real story is the 2029 framework. Management laid out a compelling AI-driven identity play – agentic identity, real-time governance, and a massive migration funnel from legacy IdentityIQ to ISC. The targets are punchy: $2.1B+ ARR (vs. $1.12B today, 24% growth), $800M in AI ARR, and 22%+ adjusted margins. That’s a 29% CAGR baked in, and the market is still digesting whether execution on migrations and AI monetization can keep the pace.
"Management presented a framework for faster growth driven by agentic identity, real-time governance, and a more scalable migration from IdentityIQ to ISC."
The broader analyst consensus is Buy, but PTs vary – $16 (Mizuho) to $23 (Cantor). Truist sits in the middle at $18, implying ~28% upside. The risk/reward hinges on whether the AI pipeline momentum is real and whether the IdentityIQ-to-ISC migration stays on schedule. If they hit the 2029 numbers, $18 looks conservative. If migration stalls, this becomes a show-me story.
BofA doubles down on pricing power. Cook’s WSJ interview confirms Apple will hike prices to offset rising memory costs — BofA had already baked in +$100 on Pro/Pro Max but now adds another $100 on top. They’re also raising ASPs on Mac/iPad while trimming unit demand across the board. The math: ~100bps gross margin headwind in products, but services margin stability (and potential upside) acts as a shock absorber.
“BofA assumes pricing goes up for Mac and iPad as well and lowers unit demand for all product categories marginally.”
The key tension is whether higher ASPs cannibalize volume enough to offset the revenue upside. BofA’s thesis hinges on Apple’s brand moat + services offset — a familiar playbook. At 35.8x trailing P/E, the stock already prices in a lot of that pricing power. Keep an eye on consumer elasticity given the macro backdrop; Cook’s “forced to raise” framing doesn’t scream demand confidence.
ENPH – Solar microinverters are getting zero airtime in the AI infrastructure narrative, but that's the point. The physical power bottleneck (gas turbine forgings, grid interconnection delays) means distributed generation becomes a de facto hedge for hyperscalers seeking to bypass utility timelines. Not a near-term catalyst, but ENPH's 20% drawdown YTD creates optionality if power shortage rhetoric escalates into policy favor for rooftop solar + storage. Track ITC extension chatter.
AME – Precision instruments and specialty metals for aerospace and energy process control. The Doncasters IPO for turbine forgings is a direct read-through: AME's electronic instruments business (pressure/temperature sensors) sees demand pull from gas turbine manufacturing and datacenter cooling loop monitoring. The enterprise API cost pullback is a mild headwind for industrial automation software sales, but AME's industrial hardware orders are more cycle-sensitive. Watch Q3 organic growth deceleration.